Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.

Blakqori G, Delhaye S, Habjan M, Blair CD, Sánchez-Vargas I, Olson KE, Attarzadeh-Yazdi G, Fragkoudis R, Kohl A, Kalinke U, Weiss S, Michiels T, Staeheli P, Weber F.

J Virol. 2007 May;81(10):4991-9. Epub 2007 Mar 7.

2.

Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Verbruggen P, Ruf M, Blakqori G, Överby AK, Heidemann M, Eick D, Weber F.

J Biol Chem. 2011 Feb 4;286(5):3681-92. doi: 10.1074/jbc.M110.154799. Epub 2010 Nov 30.

3.

La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA.

Soldan SS, Plassmeyer ML, Matukonis MK, González-Scarano F.

J Virol. 2005 Jan;79(1):234-44.

5.

Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice.

Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P.

J Virol. 2012 Oct;86(20):11223-30. Epub 2012 Aug 8.

6.

Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.

Taylor KG, Woods TA, Winkler CW, Carmody AB, Peterson KE.

J Virol. 2014 Oct;88(19):11070-9. doi: 10.1128/JVI.01866-14. Epub 2014 Jul 9.

7.

La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.

Bennett RS, Cress CM, Ward JM, Firestone CY, Murphy BR, Whitehead SS.

Virol J. 2008 Feb 11;5:25. doi: 10.1186/1743-422X-5-25.

8.

Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.

Bennett RS, Ton DR, Hanson CT, Murphy BR, Whitehead SS.

Virol J. 2007 May 8;4:41.

9.

Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections.

Hefti HP, Frese M, Landis H, Di Paolo C, Aguzzi A, Haller O, Pavlovic J.

J Virol. 1999 Aug;73(8):6984-91.

10.

Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System.

Proenca-Modena JL, Hyde JL, Sesti-Costa R, Lucas T, Pinto AK, Richner JM, Gorman MJ, Lazear HM, Diamond MS.

J Virol. 2015 Oct 14;90(1):189-205. doi: 10.1128/JVI.02276-15. Print 2016 Jan 1.

11.
12.

Innate immune response to La Crosse virus infection.

Taylor KG, Peterson KE.

J Neurovirol. 2014 Apr;20(2):150-6. doi: 10.1007/s13365-013-0186-6. Epub 2013 Jul 12. Review.

PMID:
23846288
13.

Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis.

Bridgen A, Weber F, Fazakerley JK, Elliott RM.

Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):664-9.

14.

DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.

Schuh T, Schultz J, Moelling K, Pavlovic J.

Hum Gene Ther. 1999 Jul 1;10(10):1649-58.

PMID:
10428210
15.

Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, Randall RE, Elliott RM.

J Virol. 2002 Aug;76(16):7949-55.

16.

Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies.

Ning YJ, Feng K, Min YQ, Cao WC, Wang M, Deng F, Hu Z, Wang H.

J Virol. 2015 Apr;89(8):4227-36. doi: 10.1128/JVI.00154-15. Epub 2015 Jan 28.

17.

La Crosse viremias in Mongolian gerbils (Meriones unguiculatis).

Osorio JE, Yuill TM.

Am J Trop Med Hyg. 1996 Nov;55(5):567-9.

PMID:
8940992
18.

C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response.

Brackney DE, Scott JC, Sagawa F, Woodward JE, Miller NA, Schilkey FD, Mudge J, Wilusz J, Olson KE, Blair CD, Ebel GD.

PLoS Negl Trop Dis. 2010 Oct 26;4(10):e856. doi: 10.1371/journal.pntd.0000856.

19.

Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice.

Winkler CW, Myers LM, Woods TA, Carmody AB, Taylor KG, Peterson KE.

J Neuroinflammation. 2017 Mar 24;14(1):62. doi: 10.1186/s12974-017-0836-3.

20.

Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys.

Bennett RS, Gresko AK, Murphy BR, Whitehead SS.

Virol J. 2011 Mar 24;8:135. doi: 10.1186/1743-422X-8-135.

Supplemental Content

Support Center